Thermolabile liposomes: A controlled release delivery tool in diagnosis/therapy in experimental pulmonary oedema

Current Radiopharmaceuticals

Volumn 5, Issue 2, 2012, Pages 166-174

  Santos, A C ^a   Matos, C M ^a   Oliveiros, B ^a   Almeida, T ^a   Gano, L ^b   Neves, M ^b   Ferreira, N ^a  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b Nuclear Technological Institute   (Portugal)

Author keywords

Diagnosis; Giant unilamellar vesicles; Liposomes; Pulmonary oedema; Radiopharmaceuticals; Therapy

Indexed keywords

CHOLESTEROL; DIESTEAROYLPHOSPHATIDYLCHOLINE; FLUORINE 18; GADOLINIUM; GALLIUM 67; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; INDIUM 111; IODINE 123; IODINE 124; LIPID; LIPOSOME; MERCAPTO ACETHYLTRIGLICINE TECHNETIUM TC 99M; N HYDROXYSUCCINIMIDYL HYDRAZINE NICOTINATE TECHNETIUM TC 99M; N,N BIS(2 MERCAPTOETHYL) N',N' DIETHYL ETHYLENEDIAMINE TECHNETIUM TC 99M; PENTAVALENT DIMERCAPTOSUCCINIC ACID TECHNETIUM TC 99M; PENTETIC ACID; PHOSPHATIDYL LEVO GLYCEROL; RADIOPHARMACEUTICAL AGENT; RHENIUM SULFIDE COLLOID TECHNETIUM TC 99M; TECHNETIUM 99M; TRIVALENT DIMERCAPTOSUCCINIC ACID TECHNETIUM TC 99M; UNCLASSIFIED DRUG;

CARDIOGENIC LUNG EDEMA; CONTROLLED DRUG RELEASE; DRUG ANALYSIS; DRUG DELIVERY SYSTEM; DRUG STRUCTURE; GIANT UNILAMELLAR VESICLE; ISOTOPE LABELING; LARGE UNILAMELLAR VESICLE; LUNG EDEMA; MEMBRANE VESICLE; MOLECULAR SIZE; MULTILAMELLAR VESICLE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SMALL UNILAMELLAR VESICLE; TEMPERATURE SENSITIVITY;

ANIMALS; ANTINEOPLASTIC AGENTS; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HUMANS; ISOTOPE LABELING; LIPOSOMES; PULMONARY EDEMA; RATS;

EID: 84857128664     PISSN: 18744710     EISSN: 18744729     Source Type: Journal    
DOI: 10.2174/1874471011205020166     Document Type: Review

References (108)

1. Speth, P.A.J.; van Hoesel, Q.G.C.M.; Haanen, C. Clinical pharmacokinetics of doxorubicin. Clin. Pharmacokinet., 1988, 15, 15-31.
2. Rowinsky, E.K.; Donehower, R.C. Antimicrotubule agents. In: Cancer Chemotherapy and Biotherapy: Principles and Practice; Chabner, B.A.; Longo, D.L, Ed.; Lippincott-Raven Publishers: Philadelphia, 1996; pp. 263-296.
3. Mouritsen, O.G.; Jørgensen, K. A new look at lipid-membrane structure in relation to drug research. Pharm. Res., 1998, 15, 1507-1519.
4. Chang, T.M.S. Semipermeable microcapsules. Science, 1964, 146,524-525.
5. Chang, T.M.S: The in vivo effects of semipermeable microcapsules containing L-asparaginase on 6C3HED lymphosarcoma. Nature, 1971, 229, 117-118.
6. Chang, T.M.; Poznansky, M.J. Semipermeable microcapsules containing catalase for enzyme replacement in acatalasaemic mice. Nature, New Biol., 1968, 218, 243-245.
7. Bangham, A.D.; Standish, M.M.; Watkins, J.C. Diffusion of univalent ions across the lamellae of swollen phospholipids. J. Mol. Biol., 1965, 13, 238-252.
8. Gregoriadis, G.; Leatherwood, P.D.; Ryman, B.E. Enzyme entrapment in liposomes. FEBS Lett., 1971, 14(2): 95-99.
9. New, R.R.C. Liposomes: a pratical Approach, Oxford University Press: Oxford, 1999.
10. Edwards, K.A.; Baeumner, A.J. Liposomes in analysis. Talanta, 2006, 68(5), 1432-1441.
11. Puisieux, F.; Couvreur, P.; Delattre, J.; Devissaguet, J.P. Liposomes, new sistems and new trends in their applications, Éditions de Santé: Paris, 1995, pp. 266.
12. Santos, A.C. Água Trocável do Pulmão: Contribuição para o Desenvolvimento de uma metodologia para a sua avaliação. PhD Thesis, The Faculdade de Medicina da Universidade de Coimbra: Coimbra, May 2001.
13. Immordino, M.L.; Dosio, F.; Cattel, L. Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potencial. Int. J. Nanomed., 2006, 1(3), 297-315.
14. van Berkel, T.J.; de Smidt, P.C.; van Dijk, M.C.M.; Ziere, G.J.; Bijsterbosch, M.K. Drug targeting by endogenous transport vehicles, Biochem. Soc. Trans., 1990, 18, 748-750.
15. Drummond, D.C.; Meyer, O.; Hong, K.; Kirpotin, D.B.; Papahadjopoulos, D. Optimizing liposomes for delivery of chemotherapeutic agents to solid tumours. Pharmacol. Rev., 1999, 51, 691-744.
16. Frézard, F.; Schettini, D.A.; Rocha, O.F.F.; Demicheli, C. Lipossomas: propriedades fisico-químicas e farmacológicas, aplicações na quimioterapia à base de antimónio. Quim. Nova, 2005, 28, 511-518.
17. Lasic, D.D. Novel applications of liposomes. Trends Biotechnol., 1998, 16, 307-320.
18. Frézard, F. Liposomes: from biophysics to the design of peptide vaccines. Bra. J. Med. Biol. Res., 1999, 32, 181-189.
19. Woodle, M.C.; Papahadjopoulos, D. Liposome preparation and size characterization. Methods Enzymol., 1989, 171, 193-217.
20. Derycke, A.S.L.; Witte, P.A.M. Liposome for photodynamic therapy. Adv. Drug. Del. Rev., 2004, 56, 17-30.
21. Carvalho, A.D.; Mota, L.G.; Nuna, E.A.; Wainstein, A.J.A.; Wainstein, A.P.D.L.; Leal, A.S.; Cardoso, V.N.; Oliveira, M.C. Tissue distribution evaluation of stealth pH-sensitive liposomal cisplatin versus free cisplatin in Ehrlich tumor bearing mice. Life Sci., 2007, 80, 659-664.
22. Sandip, B.T.; Udupa, N.; Rao, B.S.S.; Devi, P.U. Thermosensitive liposomes and localised hyperthermia -an effective bimodality approach for tumour management. Indian J. Pharmacol., 2000, 32, 214-220.
23. Vemuri, S.; Rhodes, C.T. Preparation and characterization of liposomes as therapeutic delivery systems: a creview. Pharm. Acta. Helvetica, 1995, 70, 95-111.
24. Batista, C.M.; Carvalho, C.M.B.; Magalhães, N.S.S. Lipossomas e suas aplicações terapêuticas: Estado da arte. Rev. Bra. Ciênc. Farmac., 2007, 43(2), 167-179.
25. Torchilin, V.P. Recent advances with liposomes as pharmaceutical carrier. Nature Rev. Drug Discov., 2005, 4, 145-160.
26. Santos, N.C.; Castanho, M.A.R.B. Lipossomas: A bala mágica acertou? Quím. Nova, 2002, 25(6B), 1181-1185.
27. Needham, D.; Evans, E. Structure and mechanical properties of giant lipid (DMPC) vesicle bilayers from 20oC below to 10oC above the liquidcrystal-crystaline phase transition at 24oC. Biochem., 1988, 27, 8261-8269.
28. Lasic, D.D. Liposomes: from physics to applications, 1st Ed.; Elsevier Science Publishers B. V.: Amsterdam, 1993; Cap. 3, pp. 63-90.
29. Medina, O.P.; Zhu, Y.; Kaimero, K. Targeted Liposomal Drug Delivery in Cancer. Curr. Pharm. Des., 2004, 10, 2981-2989.
30. Dass, C.R.; Choong, P.F.M. Carrier-mediated delivery of peptidic drugs for cancer therapy. Peptides, 2006, 27, 3020-3028.
31. Cabeça, L.F. Topologia de Complexos Formados entre Drogas/β-Ciclodextrinas/ Lipossomas/Células, Aplicando Técnicas de Ressonância Magnética Nuclear -RMN. Universidade Estadual deCampinas, Instituto de Química, Departamento de Química Orgânica, Campinas, 2009.
32. Needham, D.; R S Nunn, R.S. Elastic deformation and failure of lipid bilayer membranes containing cholesterol. Biophys. J., 1990, 58(4), 997-1009.
33. Lasic, D.D.; Papahadjopoulos, D. Medical applications of liposomes. Elsevier Science Publishers B. V.: Amsterdam, 1993.
34. Andresen, T.L.; Jensen, S.S.; Jorgensen, K. Advanced strategies in liposomal cancer therapy: Problems and prospects of active and tumor specific drug release. Prog. Lipid Res., 2005, 44, 68-97.
35. Sapra, P.; Allen, T.M. Ligand-targeted liposomal anticancer drugs. Prog. Lipid Res., 2003, 42, 439-462.
36. Mamot, C.; Drummond, D.C.; Hong, K.; Kirpotin, D.B.; Park, J.W. Liposome-based approaches to overcome anticancer drug resistance. Drug Resist. Update, 2003, 6, 271-279.
37. Andrade, C.A.S.; Correia, M.T.S.; Coelho, L.C.B.B.; Nascimento, S.C.; Santos, N.S.M. Antitumor activity of Cratylia mollis lectin encapsulated into liposomes. Int. J. Pharm., 2004, 278, 435-444.
38. ®) for platinum-resistant or refractory epithelial ovarian carcinoma: A Taiwanese gynecologic oncology group study with long-term follow-up. Gynecol. Oncol., 2006, 101, 423-428.
39. Lukyanov, A.N.; Elbayoumi, T.A.; Chakilam, A.R.; Torchilin, V.P. Tumor-targeted liposomes: doxorubicin-loaded long-circulating liposomes modified with anti-cancer antibody. J. Control Release, 2004, 100, 135-144.
40. Mazundar, T.; Anam, K.; Ali, N. A mixed Th1/Th2 response elicited by a liposomal formulation of leishmania vaccine instructs Th1 responses and resistance to Leishmania donovani in susceptible BALB/c mice. Vaccine, 2004, 22, 1162-1171.
41. Minato, S.; Iwanaga, K.; Kakemi, M.; Yamashita, S.; Oku, N. Application of polyethyleneglycol (PEG)-modified liposomes for oral vaccines: effect of lipid dose on systemic and mucosal immunity. J. Control. Release., 2003, 89, 189-197.
42. Melo, A.L.; Silva-Barcello, N.M.; Demicheli, C.; Frézard, F. Enhanced schistosomicidal efficacy of tartar emetic encapsulated in pegylated liposomes. Int. J. Pharm., 2003, 255, 227-230.
43. Chen, W.C.; Huang, L. Non-viral vector as vaccine carrier. Adv. Genet., 2005, 54,315-337.
44. Bramwell, V.W.; Eyles, J.E.; Oya, A.H. Particulate delivery systems for biodefense subunit vaccines. Adv. Drug Deliv. Rev., 2005, 57, 1347-1265.
45. Copland, M.I.; Rades, T.; Davies, N.M.; Baird, M.A. Lipid based particulate formulations for de delivery of antigen. Immunol. Cell Biol., 2005, 83, 97-105.
46. Chonn, A.; Cullis, P.R. Recent advances in liposomes technologies and their applications for systemic gene delivery. Adv. Drug Del. Rev., 1998, 30, 73-83.
47. El-Aneed, A. An overview of current delivery systems in cancer gene therapy. J. Control. Release., 2004, 94, 1-14.
48. Phillips, W.T.; Klipper, R.W.; Awasthi, V.D.; Rudolph, A.S.; Cliff, R.; Kwasiborski, V.; Goins, B.A. Plyethylene glycol-modified liposome-encapsulated hemoglobin: a long circulating red cell substitute. Pharmacol. Exp. Ther., 1999, 288, 665-670.
49. Lestini, B.J.; Sagnella, S.M.; Xu, Z.; Shive, M.S.; Richter, N.J.; Jayaseharan, J.; Case, A.J.; Kotteke-Marchant, K.; Anderson, J.M.; Marchant, R.E. Surface modification of liposomes for selective cell targeting in cardiovascular drug delivery. J. Control Release., 2002, 78, 235-247.
50. Zhang, N.; Ping, Q.N.; Huang, G.H.; Xu, W.F. Investigation of lectin-modified insulin liposomes as carriers for oral administration. Int. J. Pharm., 2005, 294, 247-259.
51. Lokling, K.E.; Fossheim, S.L.; Klaveness, J. Biodistribution of pHresponsive liposomes for MRI and a novel approach to improve the pH-responssiveness. J. Control Release., 2004, 98, 87-95.
52. Strijkers, G.J.; Mulder, W.J.M.; Van-Heeswijk, R.B.; Frederik, P.M.; Bomans, P.; Magusin, P.C.; Nicolay, K. Relaxivity of liposomal paramagnetic MRI contrast agents. MAGMA, 2005, 18, 182-192.
53. Zheng, J.; Liu, J.; Dunne, M.; Jaffray, D.A.; Allen, C. In vivo Performance of a Liposomal Vascular Contrast Agent for Ct and MR-Based Image Guidance Applications. Pharm. Res., 2007, 24(6), 1193-1201.
54. Immordino, M.L.; Dosio, F.; Cattel, L. Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potencial. Int. J. Nanomed., 2006, 1(3), 297-315.
55. Phillips, W.T.; Goins, B.A.; Bao, A. Radioactive liposomes. Rev. Nanomed. Nanobiotech., 2009, 1, 69-83.
56. 99mTc-DTPA] in mice. J. Nucl. Med., 1976, 17, 1067-1072.
57. Oku, N.; Tokudome, Y.; Tsukada, H.; Okada, S. Real-time analysis of liposomal trafficking in tumor-bearing mice by use positron emission tomography. Biochim. Biophis. Acta, 1995, 1238, 86-90.
58. Oku, N.; Tokudome, Y.; Namba, Y.; Saito, N.; Endo, M.; Hasegawa, Y.; Kawai, M.; Tsukada, H.; Okada, S. Effect of serum protein binding on real-time trafficking of liposomes with different charges analyzed by positron emission tomography. Biochim. Biophis. Acta, 1996, 1280, 149-154.
59. Phillips, W.T. Delivery of gamma-imaging agents by lyposomes. Adv. Drug Del. Rev., 1999, 37, 13-32.
60. Boerman, O.C.; Laverman, P.; Oyen, W.J.G.; Corstens, F.H.M.; Storm, G. Radiolabeled liposomes for scintigraphic imaging. Progr. Lipid Res., 2000, 39, 461-475.
61. Phillips, W.T.; Rudolph, A.S.; Goins, B.; Timmons, J.H.; Klipper, R.; Blumhardt, R. A simple method for producing technetium-99mlabeled liposome which is stable in vivo. Nucl. Med. Biol., 1992, 19,539-547.
62. Mauk, M.R.; Gamble, R.C. Preparation of lipid vesicles containing high levels of entrapped radioactive cations. Anal. Biochem., 1979, 94, 302-307.
63. Bao, A.; Goins, B.; Klipper, R.; Negrete, G.; Mahindaratne,s M.; Phillips, W.T. A novel liposome radiolabeling method using 99mTc-"SNS/S" complexes: in vitro and in vivo evaluation. J. Pharm. Sci., 2003, 92,1893-1904.
64. Gabizon, A.; Huberty, J.; Straubinger, R.M.; Price, D.C.; Papahadjpoulos, D. An improved method for in vivo tracing and imaging of liposomes using a gallium-67-desferoxamine complex. J. Liposome Res., 1989,1, 123-135.
65. Hwang, K.J.; Merriam, J.E.; Beaumier, P.L.; Luk, K.F. Encapsulation, with high efficiency, of radioactive metal ions in liposomes. Biochim. Biophys. Acta, 1982, 716, 101-109.
66. Corvo, M.L.; Boerman, O.C.; Oyen, W.J.; van Bloois, L.; Cruz, M.E.; Crommelin, D.J.A.: Storm, G. Intravenous administration of superoxide dismutase entrapped in long circulating liposomes. II. In vivo fate in a rat model of adjuvant arthritis. Biochim. Biophys. Acta, 1999, 1419, 325-334.
67. Oyen, W.J.G.; Boerman, O.C.; Storm, G.; Bloois, L.V.; Koenders, E.B.; Crommelin, D.J.A.; Van Der Meer, J.W.M.; Corstens, F.H.M. Labelled Stealth liposomes in experimental infection: An alternative to leukocyte scintigraphy? Nucl. Med. Communic., 1996, 17, 742-748.
68. Boerman, O.C.; Oyen, W.J.G.; Storm, G.; Corvo, M.L.; Bloois, L.V.; Van Der Meer, J.W.M.; Corstens, F.H.M. Technetium-99m labelled liposomes to image experimental arthritis. Ann. Rheum. Dis., 1997, 56, 369-373.
69. Carmo, V.A.S.; Oliveira, M.C.; Mota, L.G.; Freire, L.P.; Ferreira, R.L.B.; Cardoso, V.N. Technetium-99m-labelled Stealth pHsensitive Liposomes: A New Strategy to Identify Infectin in Experimental Model, Int. J. Bra. Arch. Biol. Tecnol., 2007, 50, 199-207.
70. Bao, A.; Goins, B.; Klipper, R.; Negrete, G.; Phillips, W.T. Direct 99mTc labeling of pegylated liposomal doxorubicin (Doxil) for pharmacokinetic and non-invasive imaging studies. J. Pharmacol Exp. Ther., 2004, 308, 419-425.
71. Goins, B.; Klipper, R.; Rudolph, A.S.; Cliff, R.O.; Blumhardt, R.; Phillips, W.T. Biodistribution and imaging studies of technetium-99m-labeled liposomes in rats with focal infection. J. Nucl. Med., 1993, 34, 2160-2168.
72. Awasthi, V.; Goins, B.; McManus, L.; Klipper, R.; Phillips, W.T. [99mTc] liposomes for localizing experimental colitis in a rabbit model. Nucl. Med. Biol., 2003, 30, 159-168.
73. Lee, C.M., Choi, Y.; Huh, E.J.; Lee, K.Y.; Song, H.C.; Sun, M.J.; Hwan-Jeong, J.; Chong-Su, C.; Hee-Seung, B. Polyethylene glycol (PEG) modified 99mTc-HMPAOliposome for improving blood circulation and biodistribution: the effect of the extent of PEGylation. Cancer Biother. Radiopharm., 2005, 20, 620-628.
74. Dagar, S.; Krishnadas, A.; Rubinstein, I.; Blend, M.J.; Onyuksel, H. VIP grafted sterically stabilized liposomes for targeted imaging of breast cancer: in vivo studies. J. Control Release., 2003, 91, 123-133.
75. Erdogan, S.; Ozer, A.Y., Ercan, M.T.; Hincal, A.A. Scintigraphic imaging of infections with 99m-Tc-labelled glutathione liposomes. J. Microencapsul., 2000, 17, 459-465.
76. Oyen, W.J.; Boerman, O.C.; Storm, G.; van Bloois, L.; Koenders, E.B.; Ciaessens, R.A.M.J.; Perenboom, R.M.; Crommelin, D.J.A.; van der Meer, J.W.M.; Corstens, F.H.M. Detecting infection and inflammation with technetium-99m-labeled Stealth liposomes. J. Nucl. Med., 1996, 37, 1392-1397.
77. Tilcock, C.; Yap, M.; Szucs, M.; Utkhede, D. PEG-coated lipid vesicles with encapsulated technetium-99m as blood pool agents for nuclear medicine. Nucl. Med. Biol., 1994, 21, 165-170.
78. Sou, K.; Goins, B.; Takeoka, S.; Tsuchida, E.; Phillips, W.T. Selective uptake of surface-modified phospholipid vesicles by bone marrow macrophages in vivo. Biomaterials, 2007, 28, 2655-2666.
79. Kleiter, M.M.; Yu, D.; Mohammadian, L.A.; Niehaus, N.; Spasojevic, I.; Viglianti, B.L.; Yarmolenko, P.L.; Hauck, M.; Petry, N.A.; Wong, T.Z.; Dewhirst, M.W.; Thrall, D.E. A tracer dose of technetium-99m labeled liposomes can estimate the effect of hyperthermia on intratumoral doxil extravasation. Clin. Cancer Res., 2006, 12, 6800-6807.
80. Mougin-Degraef, M.; Jestin, E.; Bruel, D.; Remaud-LeSaec, P.; Morandeau, L.; Faivre-Chauvet, A.; Barbet, J. High-activity radioiodine labeling of conventional and stealth liposomes. J. Liposome Res., 2006, 16, 91-102.
81. Dass, C.R. Drug delivery in cancer using liposomes. In: Drug delivery system; Methods in Molecular Biology, 2008, 437, 177-182.
82. Colbern, G.T.; Dykes, D.J.; Engbers, C.; Musterer, R.; Hiller, A.; Pegg, E.; Saville, R.; Weng, S.; Luzzio, M.; Uster, P.; Amantea, M.; Working, P.Q Encapsulation of the topoisomerase I inhibitor G1147211C in pegylated (Stealth) liposomes: Pharmacokinetics and antitumor activity in HT29 Colon tumor xenografts. Clin. Cancer Res., 1998, 4, 3077-3082.
83. Santos, A.C.; Ribeiro, M.J.; Ferreira, N.; Nascimento, A. Lima, J.J.P. Radiolabelled liposomes in the evaluation of the exchangeable pulmonary water space. In: Proceedings Book of the 26th International Symposium on Controlled Release of Radioactive Materials, Boston, USA, June 20-23, 1999; Torchilin, V.; Veronese, F.M, Eds.; Controlled Release Society, Inc.: Deerfield, USA, 1999; pp. 20-21.
84. Santos, A.C.; Ribeiro, M.J.; Ferreira, N.; Lima, J.J.P. Exchangeable pulmonary water space evaluation using giant liposomes. In: Proceedings of a symposium held: Modern trends in radiopharmaceuticals for diagnosis and therapy, Lisbon, Portugal, 30 March-3 April, 1998; International atomic energy agency: Vienna, Austria, 1998; pp. 207-212.
85. Santos, A.C.; Ribeiro, M.J.; Nascimento, A.; Ferreira, N.; Lima, J.J.P. Exchangeable pulmonary water space evaluation with radiolabelled giant liposomes. Eur. J. Nucl. Med., 2000, 27(8), 912.
86. Santos, A.C.; Matos, C.M.; Silva, M.A.; Perestrelo, S.L.; Borges, F.J.; Ferreira, N; Oliveiros, B. Evaluation of experimental acute pulmonary oedema -a new technique using giant unilamellar liposomes. In: Abstract book of the 29th International Symposium of Radioactive Isotopes in Clinical Medicine and Research, Bad Hofgastein, Austria, Juanuary 16-19; The Austrian Society of Nuclear Medicine, Austria, 2010; p. A154.
87. Petersdorf, R.G.; Adams, R.D.; Braunwald, E.; Isselbacher, K.J.; Martin, J.B.; Wilson, J.D. Harrison's Principles of Internal Medicine, 10th ed.; McGraw-Hill International Book Co: London, 1983.
88. Castro, R.B.P. Edema pulmonar agudo. Med. Ribeirão Preto, 2003, 36, 200-204.
89. Taylor, R.R.; Covell, J.W.; Ross, J. Jr.; Left ventricular function in experimental aorto-caval fistula with circulatory congestion and fluid retention. J. Clin. Invest., 1968, 47, 1333-1342.
90. Gonçalves, L.; Pacheco, F.; Santos, A.C.; Providência, L.A. Conventional electrocardiography as a non-invasive marker of heart remodelling in rats with arteriovenous fistulas. In: Abstract book of the 19th International Congress of Electrocardiology, Lisboa, Portugal, 1992a; p. 98.
91. Gonçalves, L.; Pacheco, F.; Santos, A.C.; Providência, L.A. Enalapril previne a remodelação miocárdica em ratos com fistula arteriovenosa se modificar o perfil do ionograma urinário. In: Livro de Resumos 13th Congresso Português de Cardiologia, Lisboa, Portugal, 1992b; p. 105.
92. Gonçalves, L.; Pacheco, F.; Santos, A.C.; Cabrita, A; Matos, M.L.B.; Providência, L.A. Can enalapril prevent the myocite changes in a model of compensated heart failure by an intravenous fistula? In: Abstract book of the 2nd International Symposium on heart failure-Mechanisms and management, Genève, Switzerland, May 16-20, 1993a; p. 67.
93. Gonçalves, L.; Pacheco, F.; Santos, A.C.; Cabrita, A.S.; Matos, M.L.B.; Providência, L.A. Enalapril prevents the structural remodeling of cardiac myocites in heart with arteriovenous fistulas. In: Abstract book of the 5th International Symposium on Cardiovascular Pharmacotherapy, Minneapolis, Minesota. USA, August 16-20, 1993b; p. 173.
94. Gonçalves, L.; Pacheco, F.; Santos, A.C.; Providência, L.A. Enalapril prevents cardiac myocite remodeling in rats with compensated heart failure without simultaneous change of urinary electrolytes. In: Abstract book of the 5th Internacional Symposium on Cardiovascular Pharmacotherapy, Minneapolis, Minesota. USA, August 16-20, 1993b; p. 175.
95. Pacheco, F.; Gonçalves, L.; Santos, A.C.; Providência, L.A. ECG convencional como marcador não invasivo da prevenção da remodelação cardíaca em ratos com fístula arteriovenosa tratados com enalapril. In: Livro de Resumos 13th Congresso Português de Cardiologia, Lisboa, Portugal, 1992a; p. 103.
96. Pacheco, F.; Gonçalves, L.; Santos, A.C.; Cabrita, A.M.S; Matos, M.L.B.; Providência, L.A. Enalapril previne a remodelação estrutural dos miócitos cardíacos em ratos com fistula arteriovenosa. In: Livro de Resumos 13th Congresso Português de Cardiologia, Lisboa, Portugal, 1992b; p. 107.
97. Albergaria, V.F.; Soares, C.M.; Araújo3, R.M.; Mendonça, W.L. Edema Pulmonar por Pressão Negativa após Hipofisectomia Transesfenoidal. Relato de Caso. Rev. Bras. Anestesiol., 2008, 58, 4, 391-396.
98. Barreto, R.A.; Hughes, J.B.; Souza, C.S.; Silva, V.D.A.; Silva, A.R., Veloso, E.S.; Batatinha, M.J.M.; Costa, M.F.D.; El-Bachá, R.S.; Costa, S.L. O alcalóide monocrotalina, extraído de Crotalaria retusa, altera a expressão de GFAP, a morfologia e o crescimento de culturas primárias de astrócitos. Rev. Bras. Saúde Prod. Anim., 2006, 7(2), 112-127.
99. Jonah, M.M.; Raham, Y.E. Tissue distribution of EDTA encapsulated within liposomes of varying surface properties. Biochim. Byophis. Acta, 1975, 401, 336-348.
100. Sato, T.; Sunamoto, J. Recent aspects in the use of liposomes in biotechnology and medicine. Prog. Lipid Res., 1992, 31, 345-350.
101. Schreier, H.; Gonzalez-Rothi, R.J.; Stecenko, A.A. Pulmonary delivery of liposomes. J. Control Release., 1993, 24, 209-223.
102. Schreier, H.; McNicol, K.J.; Ausborn, M.; Soucy, D.M.; Derendord, H.; Stecenko, A.A., Gonzalez-Rothi, R.J. Pulmonary delivery of amikacin liposomes and acute liposome toxicity in the sheep. Int. J. Pharm., 1992, 87, 183-193.
103. Taylor, K.M.G.; Farr, S.J. Liposomes for drug delivery to the respiratory tract. Drug Develop. Ind. Pharm., 1993, 19, 123-142.
104. Reeves, J.P.; Dowben, R.M. Preparation and properties of thinwalled phospholipid vesicles. J. Cell. Physiol., 1969, 73, 49-60.
105. Mossmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods, 1983, 65, 55-62.
106. Pecking, A.; Le Mercier, N.; Gobin, R.; Bardy, A.; Najean, Y. Résultats preliminaries de l'essai d'un nouveau compose pour lymphoscintigraphies isotopiques: le sulfure de rhenium colloidal marquee par du technésium-99m. J. Fr. Biophys. Méd. Nucl., 1978, 2, 117-120.
107. Strand, S.; Person, B. Quantitative lymphoscintigraphy. I: Basic concepts for optimal uptake of radiocolloids in the parasternal lymph nodes of rabbits. J. Nucl. Med., 1978, 20, 1039-1046.
108. 99mTc-DTPA, MAG3. In: Radiopharmaceutiques: chimie des radiotraceurs et applications biologiques; Comet & Vidal, Ed.; Presses Universitaires de Grenoble: Grenoble, 1998; cap. 5, pp. 495-501.